A new population study published in Redox Biology has established reference ranges for NAD and glutathione in whole blood from healthy adults. The study was led by researchers at the University of Helsinki, with NADMED co-authors.
The reference ranges are based on 330 healthy men and women aged 18 to 70, measured using NADMED’s redox profiling platform. The researchers also found distinct, disease-associated changes in NAD and glutathione levels in patient biobank samples, and showed that blood NAD does not decline with healthy aging.
The results give scientists and clinicians a baseline for identifying individuals with altered NAD and glutathione levels and for studying whether correcting these changes benefits patients.
Read the press release here. Read the study in Redox Biology here.